<DOC>
	<DOCNO>NCT00293085</DOCNO>
	<brief_summary>The objective study evaluate efficacy , safety quality life adjuvant docetaxel-cisplatin chemotherapy versus adjuvant treatment patient completely resect NSCLC Stage I-II .</brief_summary>
	<brief_title>An Open , Randomized , Multicentre , Phase II Pilot Study</brief_title>
	<detailed_description>Open multicentre , centrally randomize , two-arm parallel-group , phase II pilot-study . Duration Treatment : Arm A - 4-6 cycle Docetaxel 75mg/m2 Cisplatin 75mg/m2 day 1 every 21 day . Arm B untreated control group - best supportive care . A follow-up check-up examination perform every 3 month total three year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>histologically document NSCLC stage III Complete resection tumor amd resection margin microscopically tumor free . Surgical procedure : According necessity oncology radicality lobectomy , bilobectomy pneumectomy perform either radical mediastinal lymphadenectomy complete sample relevant lymph node area . Randomization within 60 day surgical require . Initial workup General Conditions : 1970 year , WHO performance status 02 , adequate hematological function , adequate renal hepatic function , negative pregnancy test . NSCLC stage IIIV , SCLC alveolar carcinoma Clinical evidence CNS metastases pregnant lactate patient past concurrent history malignancy NSCLC , except curatively treat non melanoma skin situ cervical carcinoma curatively treat cancer evidence disease least five year . prior concurrent antitumor therapy NSCLC surgery . Concomitant participation clinical study nonapproved experimental agent procedure . major complication surgery serious concomitant medical condition psychological , familial , sociological geographical condition permit compliance study protocol</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>Docetaxel</keyword>
</DOC>